Form 4: Vor Biopharma Inc. Executive Chakraborty Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Tirtha Chakraborty, Chief Scientific Officer of Vor Biopharma Inc., sold 5,576 shares of common stock on March 1, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On March 1, 2024, Tirtha Chakraborty, the Chief Scientific Officer of Vor Biopharma Inc., disposed of 5,576 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations associated with the settlement of restricted stock units.
- The shares were sold at a price of $2.27 per share.
- Following the transaction, Chakraborty directly owns 181,093 shares of Vor Biopharma Inc.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (sale of shares for tax obligations) and does not indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of the transaction where 5,576 shares of common stock were disposed of. |
| 03/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.